Basics Bicara Therapeutics Inc. Common Stock IPO Date: September 13, 2024 Sector: Healthcare Industry: Biotech Market Cap: $809.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 3.78% Avg Daily Range (30 D): $0.46 | 2.81% Avg Daily Range (90 D): $0.40 | 3.08% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 301 Avg Inst. Trade: $1.39M Avg Inst. Trade (30 D): $1.04M Avg Inst. Trade (90 D): $1.05M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.44M Avg Closing Trade (30 D): $.85M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 105.35K     News Oct 27, 2025 @ 12:30 PM Nanomedicine Breakthrough Technology Redefining Dr... Source: Prnewswire Jun 1, 2025 @ 5:12 PM Bicara Therapeutics Demonstrates Deep and Durable ... Source: N/A May 22, 2025 @ 9:00 PM Bicara Therapeutics Announces Publication of an Ab... Source: N/A Apr 23, 2025 @ 2:00 PM Bicara Therapeutics to Present Updated Data from O... Source: N/A Sep 16, 2024 @ 8:01 PM Bicara Therapeutics Announces Closing of $362 Mill... Source: Globe Newswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $5.37 $-.67 $-.5 Diluted EPS $5.37 $-.67 $-.5 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -121.52M $ -36.33M $ -27.39M Operating Income / Loss $ -141.12M $ -40.68M $ -32.02M Cost of Revenue $ $ $ Net Cash Flow $ -349.09M $ -318.04M $ M PE Ratio 2.80